Inhibition of the Cell Uptake of Delta and Omicron SARS-CoV-2 Pseudoviruses by N-Acetylcysteine Irrespective of the Oxidoreductive Environment

Cells. 2022 Oct 21;11(20):3313. doi: 10.3390/cells11203313.

Abstract

The binding of SARS-CoV-2 spikes to the cell receptor angiotensin-converting enzyme 2 (ACE2) is a crucial target both in the prevention and in the therapy of COVID-19. We explored the involvement of oxidoreductive mechanisms by investigating the effects of oxidants and antioxidants on virus uptake by ACE2-expressing cells of human origin (ACE2-HEK293). The cell uptake of pseudoviruses carrying the envelope of either Delta or Omicron variants of SARS-CoV-2 was evaluated by means of a cytofluorimetric approach. The thiol N-acetyl-L-cysteine (NAC) inhibited the uptake of both variants in a reproducible and dose-dependent fashion. Ascorbic acid showed modest effects. In contrast, neither hydrogen peroxide (H2O2) nor a system-generating reactive oxygen species (ROS), which play an important role in the intracellular alterations produced by SARS-CoV-2, were able to affect the ability of either Delta or Omicron SARS-CoV-2 pseudoviruses to be internalized into ACE2-expressing cells. In addition, neither H2O2 nor the ROS generating system interfered with the ability of NAC to inhibit that mechanism. Moreover, based on previous studies, a preventive pharmacological approach with NAC would have the advantage of decreasing the risk of developing COVID-19, irrespective of its variants, and at the same time other respiratory viral infections and associated comorbidities.

Keywords: COVID-19; N-acetyl-L-cysteine; SARS-CoV-2; ascorbic acid; cell internalization; hydrogen peroxide; reactive oxygen species.

MeSH terms

  • Acetylcysteine / pharmacology
  • Angiotensin-Converting Enzyme 2*
  • Antioxidants / pharmacology
  • Ascorbic Acid / pharmacology
  • COVID-19 Drug Treatment*
  • HEK293 Cells
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Oxidants / pharmacology
  • Peptidyl-Dipeptidase A / metabolism
  • Reactive Oxygen Species
  • SARS-CoV-2
  • Sulfhydryl Compounds / pharmacology

Substances

  • Angiotensin-Converting Enzyme 2
  • Acetylcysteine
  • Hydrogen Peroxide
  • Reactive Oxygen Species
  • Antioxidants
  • Peptidyl-Dipeptidase A
  • Ascorbic Acid
  • Oxidants
  • Sulfhydryl Compounds

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

This research received no external funding excepting the supply of the materials specified under Acknowledgements.